Investor Alert

Company Close Updates

Nov. 27, 2020, 5:16 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock rises Friday, outperforms market

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP advanced 1.67% to $1.22 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.92% to 12,205.85 and the Dow Jones Industrial Average DJIA rising 0.13% to 29,910.37. Corbus Pharmaceuticals Holdings Inc. closed $8.56 below its 52-week high ($9.78), which the company achieved on August 31st.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Fate Therapeutics Inc. FATE rose 1.38% to $57.92, Vanda Pharmaceuticals Inc. VNDA rose 2.48% to $12.41, and Viking Therapeutics Inc. VKTX rose 5.03% to $6.68. Trading volume (2.1 M) remained 2.8 million below its 50-day average volume of 4.9 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.